Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to Tenet Healthcare (THC) Tops Q2 EPS by 41c, provides guidance

Tenet Healthcare (THC) PT Raised to $170 at Mizuho

July 26, 2024 1:55 PM EDT

Mizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.

The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More

Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank

July 25, 2024 5:06 AM EDT

Deutsche Bank analyst Pito Chickering raised the price target on Tenet Healthcare (NYSE: THC) to $160.00 (from $155.00) while maintaining a Buy rating.

The analyst comments "Updated 2024 guidance of $3.9b EBITDA for 2024 and $3.975b at the high end is within spitting distance of consensus... More

Tenet Healthcare (THC) PT Raised to $171 at Citi

July 24, 2024 4:47 PM EDT

Citi analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $171.00 (from $139.00) while maintaining a Buy rating.

The analyst comments "2Q24 EBITDA of $945M ($915 ex retro TX) was ahead of expectations, driven by strength in USPI rev/case, hospital volume... More